3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Brain Neoplasms
9
Squamous Cell Carcinoma of Head and Neck
7
Glioblastoma
7
Polycythemia Vera
6
Gliosarcoma
6
Leukemia
5
Head and Neck Neoplasms
5
Meningioma
4
Leukemia, Myeloid, Chronic-Phase
4
Leukemia, Myeloid, Acute
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Neoplasms
3
Myelodysplastic Syndromes
3
Laryngeal Neoplasms
3
Central Nervous System Neoplasms
3
Thrombocythemia, Essential
2
Stomach Neoplasms
2
Salivary Gland Neoplasms
2
Pharyngeal Neoplasms
2
Paranasal Sinus Neoplasms
2
Oropharyngeal Neoplasms
2
Myeloproliferative Disorders
2
Myelodysplastic-Myeloproliferative Diseases
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
2
Hypopharyngeal Neoplasms
2
Glioma
2
Congenital Abnormalities
2
Carcinoma, Squamous Cell
2
Astrocytoma
2
Interventions
human papillomavirus vaccine, L1 type 16, 18
35
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
23
Papillomavirus Vaccines
14
Data Collection
7
Blood Specimen Collection
7
Vaccines
6
Vaccines, Synthetic
5
Educational Status
5
Radiotherapy, Intensity-Modulated
4
Human Papillomavirus Recombinant Vaccine nonavalent
4
Early Intervention, Educational
4
Vaginal Smears
3
Surveys and Questionnaires
3
Polymerase Chain Reaction
3
Paclitaxel
3
Methods
3
Engerix-B
3
Colposcopy
3
Cisplatin
3
halofantrine
2
fludarabine phosphate
2
fludarabine
2
aldesleukin
2
Watchful Waiting
2
Taxes
2
Patient Navigation
2
Papanicolaou Test
2
Observation
2
Light Coagulation
2
Imiquimod
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Papillomavirus Infections
×
Hydroxyurea
×
Clear all
NCT02258659
2024-09-24
OPTIMA
University of Chicago
Phase 2
Completed
62 enrolled
13 charts